After review of mid-cap #stocks, two clinical research firms earn a long-term buy rating: @CRiverLabs &amp; ICON https://t.co/gyQrZT7vwG  

$CRL #CRO $ICLR #MoneyShow #InvestSmarter #StocksToWatch #Investing #Invest #Investors #StockPicks